Literature DB >> 24605389

CLIA program and HIPAA privacy rule; patients' access to test reports. Final rule.

.   

Abstract

This final rule amends the Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations to specify that, upon the request of a patient (or the patient's personal representative), laboratories subject to CLIA may provide the patient, the patient's personal representative, or a person designated by the patient, as applicable, with copies of completed test reports that, using the laboratory's authentication process, can be identified as belonging to that patient. Subject to conforming amendments, the final rule retains the existing provisions that require release of test reports only to authorized persons and, if applicable, to the persons responsible for using the test reports and to the laboratory that initially requested the test. In addition, this final rule amends the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy Rule to provide individuals (or their personal representatives) with the right to access test reports directly from laboratories subject to HIPAA (and to direct that copies of those test reports be transmitted to persons or entities designated by the individual) by removing the exceptions for CLIA-certified laboratories and CLIA-exempt laboratories from the provision that provides individuals with the right of access to their protected health information. These changes to the CLIA regulations and the HIPAA Privacy Rule provide individuals with a greater ability to access their health information, empowering them to take a more active role in managing their health and health care.

Entities:  

Mesh:

Year:  2014        PMID: 24605389

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  24 in total

1.  Third-Party Genetic Interpretation Tools: A Mixed-Methods Study of Consumer Motivation and Behavior.

Authors:  Sarah C Nelson; Deborah J Bowen; Stephanie M Fullerton
Journal:  Am J Hum Genet       Date:  2019-06-13       Impact factor: 11.025

2.  International Policies on Sharing Genomic Research Results with Relatives: Approaches to Balancing Privacy with Access.

Authors:  Rebecca Branum; Susan M Wolf
Journal:  J Law Med Ethics       Date:  2015       Impact factor: 1.718

Review 3.  Clinical microbiology informatics.

Authors:  Daniel D Rhoads; Vitali Sintchenko; Carol A Rauch; Liron Pantanowitz
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

4.  The patient portal and abnormal test results: An exploratory study of patient experiences.

Authors:  Traber Davis Giardina; Varsha Modi; Danielle E Parrish; Hardeep Singh
Journal:  Patient Exp J       Date:  2015

5.  Evaluation of direct-to-consumer low-volume lab tests in healthy adults.

Authors:  Brian A Kidd; Gabriel Hoffman; Noah Zimmerman; Li Li; Joseph W Morgan; Patricia K Glowe; Gregory J Botwin; Samir Parekh; Nikolina Babic; Matthew W Doust; Gregory B Stock; Eric E Schadt; Joel T Dudley
Journal:  J Clin Invest       Date:  2016-03-28       Impact factor: 14.808

6.  HIPAA's Individual Right of Access to Genomic Data: Reconciling Safety and Civil Rights.

Authors:  Barbara J Evans
Journal:  Am J Hum Genet       Date:  2018-01-04       Impact factor: 11.025

7.  Integrating Rules for Genomic Research, Clinical Care, Public Health Screening and DTC Testing: Creating Translational Law for Translational Genomics.

Authors:  Susan M Wolf; Pilar N Ossorio; Susan A Berry; Henry T Greely; Amy L McGuire; Michelle A Penny; Sharon F Terry
Journal:  J Law Med Ethics       Date:  2020-03       Impact factor: 1.718

8.  Economic regulation of next-generation sequencing.

Authors:  Barbara J Evans
Journal:  J Law Med Ethics       Date:  2014       Impact factor: 1.718

9.  The FDA and genomic tests--getting regulation right.

Authors:  Barbara J Evans; Wylie Burke; Gail P Jarvik
Journal:  N Engl J Med       Date:  2015-05-27       Impact factor: 91.245

10.  Regulatory changes raise troubling questions for genomic testing.

Authors:  Barbara J Evans; Michael O Dorschner; Wylie Burke; Gail P Jarvik
Journal:  Genet Med       Date:  2014-09-25       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.